Literature DB >> 25216443

Laparoscopic ligation of inferior mesenteric artery and internal iliac artery for the treatment of symptomatic type II endoleak after endovascular aneurysm repair.

Junjie Zou1, Yueming Sun, Hongyu Yang, Hao Ma, Jun Jiang, Yuangyong Jiao, Xiwei Zhang.   

Abstract

We present a case undergoing successful laparoscopic ligation of the inferior mesenteric artery (IMA) and internal iliac artery (IIA) for the treatment of a symptomatic type II endoleak (T2E) after endovascular aneurysm repair (EVAR). The patient presented with abdominal and back pain 1 year after EVAR. Subsequent enhanced computed tomography scan showed aneurysm sac enlargement from 60 mm to 70 mm, and digital substraction angiography revealed a T2E caused by patent IMA and right IIA. Then the patient underwent successful laparoscopic ligation of the IMA and right IIA. Postprocedural angiogram demonstrated complete resolution of the type II endoleak, and no intraoperative complications occurred. Also, there was no remaining abdominal pain or back pain after the operation.

Entities:  

Keywords:  Endoleak; Endovascular aneurysm repair; Inferior mesenteric artery; Internal iliac artery; Laparoscopic ligation

Mesh:

Year:  2014        PMID: 25216443      PMCID: PMC4253946          DOI: 10.9738/INTSURG-D-13-00152.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  9 in total

Review 1.  Current status of management of type II endoleaks after endovascular repair of abdominal aortic aneurysms.

Authors:  Soo J Rhee; Takao Ohki; Frank J Veith; Harrie Kurvers
Journal:  Ann Vasc Surg       Date:  2003-04-28       Impact factor: 1.466

2.  Preoperative variables predict persistent type 2 endoleak after endovascular aneurysm repair.

Authors:  Christopher J Abularrage; Robert S Crawford; Mark F Conrad; Hang Lee; Christopher J Kwolek; David C Brewster; Richard P Cambria; Glenn M Lamuraglia
Journal:  J Vasc Surg       Date:  2010-05-15       Impact factor: 4.268

3.  Clinical significance of type II endoleak after endovascular repair of abdominal aortic aneurysm.

Authors:  Dmitri V Gelfand; Geoffrey H White; Samuel E Wilson
Journal:  Ann Vasc Surg       Date:  2006-01       Impact factor: 1.466

4.  Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2005 Jun 25-Jul 1       Impact factor: 79.321

5.  The US AneuRx Clinical Trial: 6-year clinical update 2002.

Authors:  Christopher K Zarins
Journal:  J Vasc Surg       Date:  2003-04       Impact factor: 4.268

6.  Predicting aneurysm enlargement in patients with persistent type II endoleaks.

Authors:  Carlos H Timaran; Takao Ohki; Soo J Rhee; Frank J Veith; Nicholas J Gargiulo; Hisako Toriumi; Mahmood B Malas; William D Suggs; Reese A Wain; Evan C Lipsitz
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

7.  Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up.

Authors:  C J van Marrewijk; G Fransen; R J F Laheij; P L Harris; J Buth
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-02       Impact factor: 7.069

8.  Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition.

Authors:  Salma El Batti; Frédéric Cochennec; Françoise Roudot-Thoraval; Jean-Pierre Becquemin
Journal:  J Vasc Surg       Date:  2013-03-07       Impact factor: 4.268

9.  Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes.

Authors:  John E Jones; Marvin D Atkins; David C Brewster; Thomas K Chung; Christopher J Kwolek; Glenn M LaMuraglia; Thomas M Hodgman; Richard P Cambria
Journal:  J Vasc Surg       Date:  2007-06-01       Impact factor: 4.268

  9 in total
  1 in total

1.  Abdominal Aortic Aneurysm Type II Endoleaks.

Authors:  Mohamed S Kuziez; Luis A Sanchez; Mohamed A Zayed
Journal:  J Cardiovasc Dis Diagn       Date:  2016-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.